Healthcare Animal Health Pharmaceuticals sector
Strategic acquirers, private equity (buyout funds and growth funds) firms, and valuation benchmarks for Healthcare Animal Health Pharmaceuticals
1.1 - About Healthcare Animal Health Pharmaceuticals sector
Companies in Healthcare Animal Health Pharmaceuticals develop, manufacture, and distribute therapeutic and preventive products for companion animals and livestock. Offerings span prescription and over-the-counter treatments, biologics, vaccines, parasiticides, nutritional supplements, and clinic-use supplies. These vendors combine formulation expertise with compliant production and distribution to improve animal health outcomes, control disease, and support veterinarians and producers with reliable, safe products across regulated markets.
Typical capabilities include formulation and scale-up of small‑molecule veterinary drugs, biologics and vaccine development, parasiticide and anti-infective portfolios, nutraceutical blending, dermatology and wound care topicals, anesthesia and analgesic lines, and point-of-care diagnostic kits. Many operate GMP-compliant sterile manufacturing, cold chain logistics, quality control laboratories, pharmacovigilance programs, and regulatory affairs functions to register products, manage safety data, and support distribution through clinic channels and agricultural supply networks.
Core customers include veterinary clinics and hospitals, animal health distributors, and livestock producers. These companies help reduce disease incidence, improve treatment efficacy and animal welfare, increase herd productivity, and ensure compliance with veterinary regulations. Reliable supply, evidence-based labeling, and technical support enable clinics and producers to standardize protocols, lower total cost of care, and expand preventive care programs that mitigate parasitic load and infectious risk.
2. Buyers in the Healthcare Animal Health Pharmaceuticals sector
2.1 Top strategic acquirers of Healthcare Animal Health Pharmaceuticals companies
Zomedica
- Description: Provider of veterinary health solutions offering diagnostic products, pulsed electromagnetic field therapy devices, shock wave therapy systems, and rapid hemostatic gel to improve animal health, decrease pain and bleeding, and enhance veterinary practice efficiency.
- Key Products:
- ZOM•Dx Diagnostic Suite: Integrated diagnostic products that streamline the entire process from sample collection to result analysis, enabling faster, more accurate veterinary testing and decision-making
- Assisi tPEMF Therapy Devices: LOOP Lounge
- DentaLOOP and Calmer Canine deliver targeted pulsed electromagnetic field therapy to decrease pain, inflammation and anxiety in pets, with over 50,000 animals treated
- PulseVet Shock Wave Therapy System: Regenerative shock wave technology backed by 20 years of clinical research accelerates tissue healing and supports musculoskeletal recovery in veterinary patients
- VETIGEL Hemostatic Gel: Innovative gel formula stops bleeding in less than ten seconds, reducing blood loss, shortening anesthesia time and improving surgical outcomes for veterinarians.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
2.2 - Strategic buyer groups for Healthcare Animal Health Pharmaceuticals sector
M&A buyer group 1: Veterinary Biopharma
Ceva Santé Animale
- Type: N/A
- Employees: ●●●●●
- Description: Provider of animal health solutions, offering preventive vaccines, animal welfare and pharmaceutical products for farm and companion animals, alongside equipment and related services, all developed by veterinary-led teams to advance global One Health.
- Key Products:
- Animal Health Products & Equipment: Comprehensive veterinary pharmaceuticals and specialized devices designed to treat, prevent and manage diseases across farm, companion and wildlife species, improving overall animal welfare
- Proactive Training Programs: Interactive training initiatives that teach veterinarians and farmers optimal product application, disease prevention strategies and animal care best practices, enhancing treatment outcomes and productivity worldwide
- Technical Support & Data Analyses: Expert advisory services and analytical tools that monitor treatment performance, interpret health data and optimize herd management decisions for improved operational efficiency and animal health
- Specialized Services: Customized health solution design, manufacturing and supply services delivering innovative therapies globally, aligning with One Health principles to ensure effective disease control across animal populations
Buyer group 2: ████████ ████████
●● companiesBuyer group 3: ████████ ████████
●● companies3. Investors and private equity firms in Healthcare Animal Health Pharmaceuticals sector
3.1 - Buyout funds in the Healthcare Animal Health Pharmaceuticals sector
2.2 - Strategic buyer groups for Healthcare Animal Health Pharmaceuticals sector
4 - Top valuation comps for Healthcare Animal Health Pharmaceuticals companies
4.2 - Public trading comparable groups for Healthcare Animal Health Pharmaceuticals sector
Valuation benchmark group 1: Animal Health and Pet Care Manufacturers
Zoetis
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of animal health products, offering medicines, vaccines, diagnostic products, biodevices, and genetic tests to support the care and well-being of livestock and companion animals through innovative solutions and services globally.
- Key Products:
- Livestock medicines: Treatments for cattle, swine, poultry, fish, and sheep
- Companion animal products: Healthcare solutions for dogs, cats, and horses
- Vaccines: Protective immunization for various animal species
- Diagnostic products: Tools for accurate disease detection and monitoring
- Genetic testing: DNA-based diagnostic tests for animal breeding and health